New: NCI-funded clinical trial search
Mednet Logo
CommunityGeriatric Medicine

Geriatric Medicine

Physician insights on aging-related care, polypharmacy management, cognitive decline, and geriatric syndromes.

Recent Discussions

How did the SPRINT MIND study influence your approach to blood pressure management in older patients at risk of dementia?

1 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Johns Hopkins University School of Medicine

In general, results from SPRINT MIND as well as other studies of blood pressure management in older adults have changed my thinking from being conservative in blood pressure management to favoring more aggressive management in patients able to tolerate higher doses or additional medications for bloo...

What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?

4
1 Answers

Mednet Member
Rheumatology · Tidalhealth

A workup to rule out secondary causes must be done prior to starting therapy for osteoporosis. A good history and exam are recommended to look for any clues for modifiable factors. At a minimum, one should do CMP, 25-OH vitamin D, TSH, and a 24-hour urinary calcium or calcium/creatinine ratio should...

What clinical tools and/or thresholds do you use to determine driving risk among older patients with mild cognitive impairment?

1 Answers

Mednet MemberInvited Expert
Geriatric Medicine · David Geffen School of Medicine at UCLA

I like to use the Clinical Assessment of Driver-Related Skills (CADReS). It reminds me to assess multiple domains, and reminds me which part of the MOCA is more pertinent to driving-related skills. If I have concerns, depending on the extent of my concern, I will either then file a concern with the ...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

How do you approach individualizing A1c goals in patients with dementia?

2 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Hackensack Meridian School of Medicine

This is an important question for shared decision-making. And it definitely is impacted by the severity/FAST staging of the dementia, as well as the class of medication use. As we are all aware, we do not want to use the Sulfonylurea class in older adults, especially in patients with a dementia diag...

How do you determine whether to continue anti-dementia medications (such as cholinesterase inhibitors) for patients with dementia when enrolling in hospice?

3 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Johns Hopkins University School of Medicine

In most cases, recommending discontinuation of anti-dementia medications when someone is eligible to enroll in hospice due to end-stage dementia is reasonable. Symptomatic benefit is less likely to be noticeable or meaningful at this stage (and benefit is small to modest even at earlier stages). Abi...

In your clinical practice, do you find that patients with moderate dementia due to Alzheimer's see much benefit from increasing donepezil dosing from 10 mg/day to a higher dose such as 23 mg/day?

2 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Oregon Health & Science University

Personally, I do not see much benefit in increasing to 23 mg. To be fair, I do not do this very often, as our cognitive neurologists that I trained with during fellowship rarely did this, given their experience that 23 mg did not offer noticeably more benefit and often many more side effects. I have...

How would you approach the counseling and management of a 76-year-old man presenting to clinic having purchased a direct to consumer pTau181 Elecsys test (rule out) that is positive for amyloid, with MoCA 29/30?

1 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Wake Forest University School of Medicine

I so wish this wouldn’t happen, but in reality, it’s happening! I tell people who are cognitively intact to ignore the results of the PTau test if possible. It is not a “crystal ball” that will predict their future. Is it a risk factor for developing AD in the future? Perhaps. But it’s one that is n...

In a hospitalized older adult with significant pain and delirium, in which delirium may be due either to underlying pain or use of pain medications such as narcotics, how do you approach clinical management of delirium?

1 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Massachusetts General Hospital

This is such a common and challenging scenario! Older adults experiencing delirium often cannot identify/vocalize the need for PRN medications. If there is high clinical suspicion for sub-optimally controlled pain being a contributor to the delirium, a strategy could be scheduling low-dose pain medi...

How do you decide when to give antibiotics for an older adult receiving comfort-focused care who develops signs of a symptomatic infection?

2 Answers

Mednet MemberInvited Expert
Geriatric Medicine · David Geffen School of Medicine at UCLA

In an older adult receiving comfort-focused care, the decision to use antibiotics should be guided by goals of care and likelihood of symptom relief, rather than by the presence of infection alone. The main question is whether antibiotics are likely to meaningfully improve distressing symptoms such ...

At what point would you consider stopping antidepressant treatment of late life depression after remission?

1 Answers

Mednet MemberInvited Expert
Geriatric Medicine · Oregon Health & Science University

My first step here would be to answer some clarifying questions: What is the patient's current prognosis? (If the patient has a limited life expectancy- weeks to small order months- then I would certainly consider deprescribing with more ease.) Are there any foreseeable anticipated triggers for depr...